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Dissecting the role of N-myc in development using a single
targeting vector to generate a series of alleles
A. Nagy*†, C. Moens*‡, E. Ivanyi*§, J. Pawling*, M. Gertsenstein*, 
A-K. Hadjantonakis*, M. Pirity* and J. Rossant*†
The N-myc proto-oncogene is expressed in many organs
of the mouse embryo, suggesting that it has multiple
functions. A null mutation leads to mid-gestation lethality
[1–4], obscuring the later roles of the gene in
organogenesis. We have generated a multi-purpose gene
alteration by combining the potential for homologous and
site-specific recombination in a single targeting vector, and
using the selectable marker for neomycin-resistance, neo,
to downregulate gene activity. This allowed us to create a
series of alleles that led to different levels of N-myc
expression. The phenotypes revealed a spectrum of
developmental problems. The hypomorphic allele
produced can be repaired in situ by Cre-recombinase-
mediated DNA excision. We show here for the first time
the use of a single targeting vector to generate an allelic
series. This, and the possibility of subsequent lineage-
specific or conditional allele repair in situ, represent new
genome modification strategies that can be used to
investigate multiple functions of a single gene. 
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Results and discussion
The targeting vector (Figure 1a) was designed to have a dual
function: first to introduce a point mutation into the N-myc
gene that leads to a null mutation, and second to create a
Cre-recombinase-repairable hypomorphic N-myc allele. The
3′ homology arm of the targeting vector was used to engi-
neer two point mutations: one changed the first leucine of
the leucine zipper to proline (L423P), generating an inactive
protein; the other (22 bp downstream) was neutral, creating
a new site for the restriction enzyme PvuII. Depending on
the recombination site (Figure 1b), the mutations may or
may not be co-introduced. Of the 12 homologous recombi-
nant cell lines, three contained the new PvuII site
(Figure 1d). The presence of the L423P mutation was con-
firmed by sequencing. This allele was named N-mycPneo
(Figure 1c). In the remaining lines, only the neo marker was
inserted (N-mycLneo allele, Figure 1c,d). Transient expres-
sion of Cre recombinase in these lines resulted in excision of
neo, by site-specific recombination between the loxP sites in
an average of 1 in 29 colonies (Figure 1f), thereby generating
two more alleles: N-mycPlox from N-mycPneo, and N-mycLlox
from N-mycLneo (Figure 1e). The N-mycLlox allele is function-
ally equivalent to wild type, suggesting that the intronic loxP
insertion allowed normal gene function.
The N-mycPlox and N-mycPneo alleles had identical pheno-
types; therefore data were pooled. In the F1 generation,
kinks were observed in the proximal part of the tail
because of vertebral fusion, with 25% penetrance in an
outbred and 100% penetrance in an inbred (strain 129)
background. Homozygous F2 embryos died at 11.5 days
post coitum (dpc) and had the same phenotypes as the
N-myc null alleles [1–4]. Loss of function was due to
altered protein activity and not to altered transcript levels,
as equal levels of transcript from both mutant and wild-
type (wt) alleles (Figure 2a, lanes 4–6) were detected by
an allele-specific transcription assay (ASTA).
Homozygotes for the N-mycLneo allele were viable, but had
a vertebral fusion phenotype that was slightly more severe
than that observed in heterozygotes for the N-mycPlox
allele. As detected by ASTA (Figure 2a), there was a 60%
decrease in representation of the neo-containing allele in
9.5 dpc embryos in both the N-mycPneo/wt (lanes 2,3) and
N-mycLneo/N-mycPlox (lanes 7,8) lines. Interestingly, we
identified an alternative, aberrant splice product derived
from the N-mycLneo allele. Exon 2 was spliced to 5 bp 5′ of
the neo ATG. At 15 bp 3′ of the neo stop codon, the tran-
script was spliced back to exon 3 (Figure 2b). A putative
fusion protein from this mRNA would lack exon 3, which
encodes the basic helix-loop-helix domain that is essential
for biological activity, and would therefore act as an
N-Myc protein null. This intronic interference is similar in
nature to that recently reported for an FGF8 alteration [5].
N-mycLneo/N-mycPlox compound heterozygous embryos
having 20% functional N-Myc levels were produced. These
hypomorphs died at term because of a failure to initiate
breathing. Lung development was compromised
(Figure 3a), as was observed in our earlier study [6]. In addi-
tion, the compact myocardium was extremely thin
(Figure 3b). By 12.5 dpc, N-mycLneo/N-mycPlox embryos
appeared smaller than the N-mycLneo/wt littermates. The
yolk sac of 15.5 dpc embryos had an opaque appearance
(Figure 3d) because of a deficiency in the remodeling of
capillaries into larger vessels that normally results in a trans-
parent yolk sac.
The length of the vertebral column was decreased by 40%
(Figure 3c,f), and a reduction in size of the vertebral bodies
(Figure 3e) was observed. In addition to vertebral fusion
(Figure 3f, green arrows), split ossification of vertebral
bodies was observed (Figure 3f, yellow arrows), possibly a
consequence of radial ossification suppression by the rem-
nants of the notochord forming the intervertebral disks. Car-
tilage staining of 15.5 dpc embryos (Figure 3g) supported
the role of notochord in this phenotype. The small number
of condensing chondrocytes appeared unable to entrap the
notochord in segments of the vertebral column (Figure 3h);
thus the notochord did not regress (Figure 3h,i). By
15.5 dpc, chondrocytes normally form clearly separated,
highly condensed segments. At low levels of N-Myc, the
boundaries of chondrocytes were not clearly defined, as sep-
arations were incomplete (Figure 3i). The vertebral-fusion
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Figure 1
(a) Design of the targeting vector and the
positions of the point mutations introduced into
the 3′ homology arm. PGK, phosphoglycerate
kinase gene promoter; tk, thymidine kinase gene;
pA, polyadenylation site. The red dot indicates
the mutated exon. (b) The two possibilities for
recombination in the 3′ homology arm leading to
the generation of two different phase I alleles: 
N-mycLneo and N-mycPneo shown in (c). (d) The
diagnostic Pvull digest of the PCR products over
the putative mutated area to detect the co-
introduction of mutations with the neo marker. 
(e) Phase ll alleles N-mycLlox and N-mycPlox are
generated after transient expression of the Cre
recombinase in the targeted cell lines and site-
specific recombination between the loxP sites.
(f) PCR detection of Cre-mediated excision of
the neo marker (see Supplementary material
published with this paper on the internet). Pr1,
Pr2, Pr3 and Pr4 are primers for PCR and are
described in Supplementary material.
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(a) Analysis of Pvull-digested reverse transcription (RT)–PCR products by
agarose gel electrophoresis to measure the degree of compromised
transcription caused by the neo insertion into intron 2. The relative activities
indicated below lanes 2–8 reflect the intensity of each upper band relative to
the corresponding lower band, as determined by phosphorimager analysis.
(b) Location and sequence of the cryptic splice acceptor and splice donor
sites (green circles; lower-case letters in green box below) in the
PGK–neo–pA vector (pink circles, splice acceptor and donor sites in N-myc).
phenotype appeared to be a consequence of the failure of
proper condensation of the chondrocytes. 
A transgenic mouse line expressing Cre recombinase
(TgN(CMV–Cre)1AN) was crossed to the N-mycPlox/wt
mice. The resulting hemizygous cre;N-mycPlox/wt animals
were crossed with N-mycLneo/N-mycLneo partners to test
whether the perinatal lethality of N-mycLneo/N-mycPlox
newborns could be rescued in situ by the Cre-recombi-
nase-mediated excision of neo from the N-mycLneo allele.
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Figure 3
Phenotypes of the compound heterozygous
N-mycLneo/N-mycPlox (hyp) newborns and
15.5 dpc embryos compared to their wild-type
(wt) littermates: (a) lung; (b) heart; (c) skeleton
(lateral view); (d) yolk sac (inserts show cross
sections); (e) first lumbar vertebra; (f) vertebral
column (ventral view); (g) cartilage of 15.5 dpc
embryos; (h) lumbar vertebrae of 15.5 dpc
embryos; and (i) condensing chondrocytes in the
caudal region of 15.5 dpc embryos.
We examined 32 animals in which the cre transgene was
not transmitted, and found only the N-mycLneo/wt geno-
type among pups that survived to birth. Of the 35 animals
that transmitted the cre transgene, we found close to equal
numbers of N-mycLlox/wt (15 out of 35) and N-mycLlox/
N-mycPlox (16 out of 35) newborns. Thus Cre-mediated
excision rescued the perinatal lethal N-mycLneo/N-mycPlox
embryos by converting them to N-mycLlox/N-mycPlox. The
excision was incomplete in only four animals. Lineage-
specific repair was demonstrated by an lck-promoter-
driven cre transgenic line (see Supplementary material).
Single-vector targeting generates at least two alleles: the
allele with the mutation and a hypomorphic allele. The
first allows the study of the mutation, and the second
allows the generation of a series of hypomorphic geno-
types. As hypomorphic alleles created this way are
repairable by Cre recombinase, lineage-specific gene
repair may further facilitate the exploration of multiple
gene functions. The strength of interference of an intronic
insertion can be varied; for example, an inverted neo
sequence encodes a cryptic splice acceptor site, and is
stronger than when neo is in the same orientation [7,8].
Therefore, this approach can be applied to genes requiring
higher levels of interference to produce hypomorphs with
informative phenotypes.
Materials and methods
Production of mutant alleles and embryos/animals
The targeting vector was electroporated into R1 embryonic stem (ES)
cells [9]. Colonies were screened for homologous recombination by
PCR and Southern analysis. At least two independent lines for each
allele were introduced into the germ line. The Cre recombinase was
transiently expressed in ES cells using standard electroporation condi-
tions with pBS185 circular plasmid [10]. Mutant ES cells were aggre-
gated with 8-cell-stage CD1 embryos. An hCMV–Cre transgenic
mouse line (TgN(CMV–Cre)1AN) was produced by pronuclear injec-
tion of pBS185.
Measurement of the transcriptional activity of the modified
N-myc allele
N-mycPlox/wt, N-mycLneo/N-mycPlox or N-mycPneo/N-mycLlox 9.5 dpc
embryos with only one PvuII-digestible allele served as templates for
RT–PCR. PCR products were digested with PvuII and analyzed by
Southern blotting using the purified PvuII-digested fragment as probe.
This sequence was fully represented in both PvuII-digested and undi-
gested bands. Band densities were measured using ImageQuant soft-
ware (Molecular Dynamics).
Histology and skeletal preparation
Embryos were processed using standard procedures, sectioned at
7 µm and stained with hematoxylin and eosin. Skeletal preparations
and cartilage staining were performed as previously described [11,12]
Supplementary Material
A figure showing repair of the N-mycLneo hypomorphic allele and rescue
of the N-mycLneo/N-mycPlox perinatal lethal genotype, and additional
methodological details are published with this paper on the internet.
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Materials and methods
Design of targeting vector and targeting
A vector with loxP sites flanking the neo gene was created by replac-
ing the LEU2 gene of the pBS67 plasmid [S1] with the PGK pro-
moter–neo–PGK pA sequence from the pPNT vector [S2]. Using
pN7.7 DNA [S3] as template, two point mutations were introduced
into exon 3 of the N-myc gene by PCR-based mutagenesis. The first
introduced mutation changed the codon for the leucine at a position
423 to a codon for proline. A neutral second point mutation was
placed 22 bp 3′ of the first (at amino acid 430) thereby creating a
novel PvuII site. A BamHI–BclI fragment of pN7.7 was used as a 5′
homology arm to the N-myc locus and a BclI–HincII fragment from the
mutated genomic vector was used for the 3′ homology arm. These two
fragments were placed on either side of the loxP-flanked neo cassette.
The neo gene was positioned in the same orientation as the N-myc
gene. The tk gene from the pPNT vector was placed at the 3′ end of
the 3′ homology arm of the targeting vector, providing a marker for
negative selection (see Figure 1a). 
The targeting vector was electroporated into R1 ES cells [S4] as
described previously [S5]. Double-resistant colonies were screened
by PCR (40 cycles, 94°C for 1 min, 57°C for 1 min, 72°C for 2 min,
extension increased for 2 sec per cycle) using the following primers.
Pr1: 5′-CTCGAGGGTTCGAAATCGGAT-3′ (polylinker sequence in
the junction between the 3′ loxP site and intron 2); and Pr2: 5′-
ACAAAACATCCCCCTCAAACA-3′ (an N-myc sequence lying
outside of the targeting vector in the HincII–EcoRI region; see Figure
1b). Candidate targeted lines were double-checked for correct homol-
ogous recombination at both ends by Southern blot analysis using
EcoRI-digested DNA probed with the external EcoRI–BamHI fragment.
The presence of the L423P mutation was confirmed by sequencing;
this allele was named N-mycLneo. The two possibilities for the recombi-
nation within the 3′ homology arm gave two different alleles (see
Figure 1c), which could be discriminated by PvuII digestion of the
PCR products covering the putative mutated region of the targeted
cell lines (see Figure 1d). 
Removal of the neo selectable marker by transient expression
of the Cre recombinase in ES cells
To remove the neo selectable marker in vitro, 50 µg/ml pBS185 cir-
cular plasmid [S6] containing the cre gene driven by an hCMV pro-
moter was electroporated into the N-mycLneo and N-mycPneo
targeted ES cells. After electroporation, the cells were plated
sparsely as single cells (1000 cells per 10 cm culture plate), result-
ing in 100–150 colonies per plate after a 7 day period. The colonies
were screened by PCR for excision resulting in N-mycLlox and N-
mycPlox alleles (upper Pr3: 5′-TTTCTGCCACATCCTCAAGTT-3′,
and lower: Pr4: 5′-CCC CGTGTCCTGCCCCCTACC-3′; both were
N-myc sequences flanking the neo cassette insertion) (see Figure
1e). The endogenous N-myc allele produced a 959 bp PCR
product. The targeted allele should produce a 2992 bp fragment;
however, because of its large size, no product was detected under
our conditions. If the neo gene was excised, a 1040 bp product was
amplified. Positive colonies were expanded, and the excision of neo
was confirmed by checking the G418 sensitivity of the cell lines and
by Southern blot analysis.
Direct injection of circular hCMV–Cre expression plasmid into
the pronucleus
The pBS185 circular plasmid [S6] was directly injected at a concentra-
tion of 5 ng/µl into the pronucleus of F1 zygotes fertilized by germ-line-
transmitting chimeric males. The action of Cre recombinase was tested
by PCR on earpunch samples from animals that were born from these
injected embryos. Two pairs of primers were used in the same amplifica-
tion reaction: Pr7: 5′-ATCTCCTGTCATCTCACCTTGC-3′, and Pr8: 5′-
ACCCCACCCCCACCCCCGTAG-3′, which amplify a 658 bp product
from the neo–PGK pA junction; and Pr5: 5′-AGCATCTGT CGC-
CAAGTCTAC-3′ and Pr6: 5′-TCCTCGTCATCCTCATCATCT-3′, which
amplify the loxP insertion region and produce a product of 367 bp from
the wild-type allele and a 459 bp sequence from the loxP-containing
allele after the neo gene is removed. The conditions for the amplification
were 94ºC for 1 min, 59ºC for 1 min and 72ºC for 3 min for 40 cycles.
Mating with a hCMV–cre transgenic mouse line
We created an hCMV–cre transgenic mouse line (TgN(CMV–Cre)1AN)
by pronuclear injection of the cre-containing HindIII fragment of the
pBS185 plasmid. This transgenic line was crossed with animals transmit-
ting the neo-containing N-myc alleles (N-mycPneo and N-mycLneo). The
removal of the neo gene by site-specific recombination was tested among
the offspring using the four-primer PCR screen described in the previous
paragraph. As this four-primer system detects the presence of the neo-
containing allele, the loxP-containing allele and wild-type alleles, it was
used as a general screen in most of the genotypings. The presence of the
cre transgene was tested in ear punch DNA by a three-primer PCR in
which one of the upper primers (5′-CATTTCGTGATGAATGCCAC-3′)
was specific for the cre gene, the other upper primer (5′-CCG-
TAGCTCCAGCTTCAC C-3′) sequence was taken from the endogenous
metallothionein (MT) gene and the common lower primer (5′-
ACTTGCAGTTCTTGCAGG C-3′) from the MT poly(A) sequence, which
is the polyadenylation signal for the cre transgene in pBS185. These
primers normally create two products: a 668 bp band from the cre trans-
gene and a 588 bp band from the endogenous MT gene at the PCR con-
ditions: 94ºC for 1 min, 60ºC for 1 min, 72ºC for 1.5 min, for 35 cycles.
However, our TgN(CMV–Cre)1AN transgenic line contains a high-copy-
number cre transgene and, as a consequence, in the transgenic animals
the amplification from the transgene compromises the amplification from
the MT gene and only the 668 bp product was usually detected.
Transgenic lines expressing Cre recombinase and efficiency
of excision
Approximately 90% of offspring inheriting the cre transgene from one of
parents excised the selectable marker completely from the neo-contain-
ing allele. Excision was also complete in the germ line as these animals
transmitted the neo-excised allele to the next generation. In contrast,
offspring negative for the cre transgene retained the neo-containing
allele. About 5% of the offspring inherited the cre transgene but no
excision of the neo gene occurred. This indicates that, although the effi-
cacy of the cre transgene is very high, it is not active in all embryos that
inherit it. In the remaining 5% of the offspring mosaicism was observed.
The lck–cre transgenic mice were kindly provided by Junji Takeda. In this
line of transgenic mice the Cre recombinase is expressed, and excises
loxP-flanked sequences specifically in T cells. Within a few kilobase range
the specific excision is complete (J. Takeda, personal communication).
Supplementary material
Genotyping at the N-myc locus after germ-line transmission
After germ-line transmission, two pairs of primers were used in the
same amplification reaction as for routine genotyping of N-myc. The
primers 5′-ATCTCCTGTCATCTCACCTTGC-3′ and 5′-ACCCCA
CCCCCACCCCCGTAG-3′ amplify a 658 bp product from the
neo–PGK pA junction. The pair 5′-AGCATCTGTCGCCAAGTCTAC-
3′ and 5′-TCCTCGTCATCCTCATCATCT-3′ amplify the loxP insertion
region and produce a product of 367 bp from the wild-type allele, and
459 bp from the loxP-containing allele after the neo gene is removed.
Measurement of the transcriptional activity of the modified N-
myc allele by ASTA
The novel PvuII site, introduced into exon 3, allowed us to distinguish
and compare the level of mRNA expression from the altered and the
wild-type N-myc alleles in heterozygous embryos by PvuII digestion of
an RT–PCR-amplified product across the mutations. 
The effect of the transcriptional interference caused by the neo selec-
table marker inserted into intron 2 was measured using RNA from
N-mycPneo/wt embryos as a template. To exclude the possibility of any
bias due to heterologous pairing between the two PCR products,
which could result in a bias toward the PvuII-indigestible component,
we also performed the measurement on N-mycLneo/N-mycPlox 9.5 dpc
embryos. In this genotype, the neo-inserted allele was PvuII indi-
gestible. The same drop in representation of the neo-containing allele
was observed in both situations, excluding any possible bias of the
assay. Comparing the band densities, we estimated that the neo selec-
table marker placed in an intron and having the same orientation to the
N-myc gene reduced mRNA expression by approximately 60%. 
The ASTA on N-mycPneo/wt and N-mycLneo/N-mycPlox 9.5 dpc embryos
showed the same 60% decrease in representation of the neo-contain-
ing allele. The level of decrease appears to be tissue independent as
no statistically significant variation could be reproducibly detected
from repeated ASTA performed on several organs at different embry-
onic stages.
For the RT–PCR, 5′-CGGTGGCTGCTCCTGCTCGTG-3′ as upper,
and 5′-TGTCCTGCCCCCTACCCAGAT-3′ as lower primers were
chosen from exon 2 and exon 3 of N-myc, respectively. The reverse
transcriptase reaction was performed using the Ready-to-Go T-primed
First-Strand Kit (Pharmacia). After RT the PCR was run for 35 cycles
(95°C for 1 min, 60°C for 1 min, 72°C for 2 min). The PCR products
were subsequently PvuII digested and analyzed by Southern blot using
a purified PvuII-digested fragment from the above PCR product as
probe. This sequence was fully represented in both PvuII-digested and
undigested bands. The band densities were then measured using
ImageQuant software (Molecular Dynamics).
In situ repair of the N-mycLneo hypomorphic allele and rescue
of N-mycLneo/N-mycPlox perinatal lethal genotype
In situ rescue of the perinatal lethality of N-mycLneo/N-mycPlox newborns
by the Cre-recombinase-mediated excision of neo from the N-mycLneo
allele is shown in Figure S1a. This Cre-mediated excision rescued the
perinatal lethal N-mycLneo/N-mycPlox embryos by converting them to N-
mycLlox/N-mycPlox. A representative experiment is shown in Figure S1a.
Of 35 Cre-positive animals, we found two N-mycLneo/+ (Figure S1b, off-
spring 5) and two mosaic N-mycLneo/N-mycPlox; N-mycLlox/N-mycPlox
animals (data not shown), which indicated that, in 10% of the cases,
the Cre-mediated excision was not complete or did not occur. 
Additionally, an lck-promoter-driven cre transgenic line was used to
demonstrate that the neo-derived transcriptional interference was
repairable in a specific cell lineage, in this case T cells (Figure S1c,
lanes 3,5,6).
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S2 Supplementary material
Figure S1
(a) Rescue of the perinatal lethal hypomorphic phenotype in situ by
introduction of a cre transgene into the compound heterozygous
genotype. (b) Genotype analysis of offspring from a cross between an
N-mycLneo/N-mycLneo female and +/N-mycPlox male. The male was also
hemizygous for a CMV—cre transgene from the TgN(CMV–Cre)1AN
line. (c) Repair of the hypomorphic N-mycLneo allele exclusively in the T
cell lineage by a cre transgene under the regulation of an lck promoter.
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